Most common side effects include gastrointestinal (GI) symptoms such as nausea, diarrhea, constipation, vomiting. This is the primary reason that these medications are up-titrated (increased over periods of time). It helps introduce them to the body and reduce side effects that could disrupt the medication therapy and impede weightloss.

Although both medications are GLP-1 medications; semaglutide has longer lasting effects that allows it to be injected once weekly vs. daily dosing that is required with liraglutide.

Yes. Semaglutide would be the next best option.

In approximately 13 hours after initial injection, the dose will have decreased by ½ of total dose for the day. This is called medication half-life. Due to this rule of medication elimination, it would take approximately 3 days for the medication to be eliminated.

Medications work differently in a range of people for various reasons. Clinical. Evidence has shown weightloss between 6-15% on average.

This medication is contraindicated in patients with known hypoglycemia or type 1 diabetes mellitus (DM1) as it could worsen hypoglycemic (low blood sugar) episodes. This medication is not recommended in any patients with a personal history or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2; condition that causes tumors in more than one gland in the body). Liraglutide is not for women who are pregnant, breast feeding or planning to become pregnant within a year of medication initiation

Liraglutide has not proven to. Directly reduce depression however indirect effect of reduced depression should be considered. Think about it: If you are finally losing the weight and feeling good about your body and self, wouldn’t that improve your overall mindset?

There are no concrete lists of do NOT eat foods however it is BEST to steer clear of highly processed foods and drinks high in sugar. Intake of the mentioned food could worsen GI (stomach) side effects and slow weightloss progress.

Studies have shown that dose-dependent liraglutide decreased wakefulness and increased non-rapid eye movement (NREM) sleep at therapeutic doses.

Foods high in protein, particularly plant protein; Provide necessary protein required by the body, help aid ongoing weightloss, maintain muscle and help make you feel fuller for a longer period of time.

Read more about Diet while on liraglutide.

Common side effects include feeling nauseous, vomiting, diarrhea, and stomach pain. These side effects usually get better as your body adjusts to the medication (Obesity Reviews, 2019).

Yes, Liraglutide can be taken with other diabetes medicines, but you should not take it with other GLP-1 receptor agonists (Circulation, 2020).

You might start feeling less hungry within a few days, but it can take a few weeks to see changes in your weight or blood sugar levels (Journal of Endocrinology, 2021).

Yes, Liraglutide has been shown to reduce the risk of heart problems like heart attacks or strokes in people with type 2 diabetes (American Journal of Medicine, 2020).

You can take Liraglutide as long as your doctor thinks it’s necessary. Some people take it for a long time to help manage their weight and blood sugar (Obesity Reviews, 2019).

American Diabetes Association. (2021). How Liraglutide Works to Control Blood Sugar Levels.

Journal of Clinical Endocrinology & Metabolism. (2020). Effects of GLP-1 Agonists on Appetite and Weight Loss.

New England Journal of Medicine. (2017). Liraglutide and Weight Loss in Clinical Trials.

Diabetes Care. (2019). Impact of Liraglutide on HbA1c Levels in Type 2 Diabetes.

Lancet. (2018). Cardiovascular Outcomes with Liraglutide.

Obesity Reviews. (2019). Long-Term Efficacy of Liraglutide in Obesity Management.

Diabetes, Obesity and Metabolism. (2020). Visceral Fat Reduction with Liraglutide Therapy.

Clinical Diabetes. (2019). Glycemic Control with GLP-1 Receptor Agonists.

Circulation. (2020). Liraglutide’s Cardioprotective Benefits in High-Risk Patients.

Journal of Endocrinology. (2021). Sustainability of Weight Loss with Liraglutide.

Obesity Medicine. (2019). Liraglutide for Patients with BMI Over 30.

Journal of Clinical Endocrinology. (2020). Liraglutide’s Effectiveness in Patients with Comorbidities.

Diabetes Spectrum. (2020). Targeting Type 2 Diabetes with Liraglutide.

American Journal of Medicine. (2020). Patient Success Stories with Liraglutide.

Liraglutide is a GLP-1 receptor agonist injection that helps control appetite, reduce cravings, and improve blood sugar levels. It supports sustainable weight loss when combined with a healthy lifestyle.

Liraglutide requires daily dosing, compared to the weekly dosing of Semaglutide and Tirzepatide. It is often chosen for patients seeking an alternative GLP-1 option with proven weight loss benefits.

Liraglutide is ideal for individuals with a BMI of 27 or higher and weight-related conditions or a BMI of 30 or more. It’s especially helpful for those needing better appetite control and metabolic improvements.

Side effects may include mild nausea, headaches, or fatigue, which typically lessen over time. Our team customizes your dosing schedule to minimize discomfort.

Patients often experience significant weight loss, improved energy levels, and better control over eating habits within the first few months of treatment.